Display Settings:

Format

Send to:

Choose Destination
    Cardiovasc Res. 2010 Nov 1;88(2):250-6. Epub 2010 Aug 4.

    Mitochondrial SIRT3 and heart disease.

    Source

    Department of Surgery, Committee on Cellular and Molecular Physiology, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL 60637, USA.

    Abstract

    Sirtuins are emerging as key regulators of many cellular functions including metabolism, cell growth, apoptosis, and genetic control of ageing. In mammals there are seven sirtuin analogues, SIRT1 to SIRT7. Among them SIRT3 is unique because this is the only analogue whose increased expression has been found to be associated with extended lifespan of humans. SIRT3 levels have been shown to be elevated by exercise and calorie restriction. Although the role of SIRT3 in cell biology is only beginning to be understood, initial studies have shown that SIRT3 plays a major role in free fatty acid oxidation and maintenance of cellular ATP levels. In the heart SIRT3 has been found to block development of cardiac hypertrophy and protect cardiomyocytes from oxidative stress-mediated cell death. Similarly, SIRT3 has been reported to have tumour-suppressive characteristics. In this article, we review the known effects of SIRT3 in different tissues and relate them to the protection of cardiomyocytes under stress.

    PMID:
    20685942
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2952535
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk